12 trends tracked about this subject — the full history, oldest to newest below.
New clinical data suggests GLP-1 weight-loss medications may significantly reduce the prevalence and severity of sleep apnea symptoms.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Medical experts and news outlets are raising alarms over potential muscle loss and frailty risks associated with GLP-1 weight loss drugs in older populations.
Patients are facing restricted access to GLP-1 drugs like Ozempic and Wegovy due to high costs and restrictive insurance policies.
Medicare initiates a pilot program providing coverage for GLP-1 weight-loss medications beginning July 1, 2026.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.